Huth et al. reported an increased phosphorylation of MEK1/2 in CD56Bright NK cells in ME/CFS patients [23], which may explain previously reported increased IFN-γ production [25]. This evidence concerns the gene MAP2K1 and myalgic encephalomeyelitis/chronic fatigue syndrome.